127 related articles for article (PubMed ID: 2757894)
1. Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.
Ward SA; Watkins WM; Mberu E; Saunders JE; Koech DK; Gilles HM; Howells RE; Breckenridge AM
Br J Clin Pharmacol; 1989 Jun; 27(6):781-7. PubMed ID: 2757894
[TBL] [Abstract][Full Text] [Related]
2. Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults.
Watkins WM; Mberu EK; Nevill CG; Ward SA; Breckenridge AM; Koech DK
Trans R Soc Trop Med Hyg; 1990; 84(4):492-5. PubMed ID: 2091335
[TBL] [Abstract][Full Text] [Related]
3. OCT1 Deficiency Affects Hepatocellular Concentrations and Pharmacokinetics of Cycloguanil, the Active Metabolite of the Antimalarial Drug Proguanil.
Matthaei J; Seitz T; Jensen O; Tann A; Prukop T; Tadjerpisheh S; Brockmöller J; Tzvetkov MV
Clin Pharmacol Ther; 2019 Jan; 105(1):190-200. PubMed ID: 29882324
[TBL] [Abstract][Full Text] [Related]
4. Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man.
Edstein MD; Veenendaal JR; Scott HV; Rieckmann KH
Chemotherapy; 1988; 34(5):385-92. PubMed ID: 3180907
[TBL] [Abstract][Full Text] [Related]
5. Human pharmacokinetics of proguanil and its metabolites.
Bygbjerg I; Ravn P; Rønn A; Flachs H; Hvidberg EF
Trop Med Parasitol; 1987 Jun; 38(2):77-80. PubMed ID: 3629140
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.
Kaneko A; Bergqvist Y; Takechi M; Kalkoa M; Kaneko O; Kobayakawa T; Ishizaki T; Björkman A
J Infect Dis; 1999 Apr; 179(4):974-9. PubMed ID: 10068594
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism.
Helsby NA; Ward SA; Edwards G; Howells RE; Breckenridge AM
Br J Clin Pharmacol; 1990 Oct; 30(4):593-8. PubMed ID: 2291871
[TBL] [Abstract][Full Text] [Related]
8. Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans.
Funck-Brentano C; Bosco O; Jacqz-Aigrain E; Keundjian A; Jaillon P
Clin Pharmacol Ther; 1992 May; 51(5):507-12. PubMed ID: 1587064
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by omeprazole of proguanil metabolism: mechanism of the interaction in vitro and prediction of in vivo results from the in vitro experiments.
Funck-Brentano C; Becquemont L; Lenevu A; Roux A; Jaillon P; Beaune P
J Pharmacol Exp Ther; 1997 Feb; 280(2):730-8. PubMed ID: 9023285
[TBL] [Abstract][Full Text] [Related]
10. The multiple dose pharmacokinetics of proguanil.
Helsby NA; Edwards G; Breckenridge AM; Ward SA
Br J Clin Pharmacol; 1993 Jun; 35(6):653-6. PubMed ID: 8329294
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women.
Na-Bangchang K; Manyando C; Ruengweerayut R; Kioy D; Mulenga M; Miller GB; Konsil J
Eur J Clin Pharmacol; 2005 Sep; 61(8):573-82. PubMed ID: 16041597
[TBL] [Abstract][Full Text] [Related]
12. Relationship between proguanil metabolic ratio and CYP2C19 genotype in a Caucasian population.
Hoskins JM; Shenfield GM; Gross AS
Br J Clin Pharmacol; 1998 Nov; 46(5):499-504. PubMed ID: 9833604
[TBL] [Abstract][Full Text] [Related]
13. Multiple-dose pharmacokinetic study of proguanil and cycloguanil following 12-hourly administration of 100 mg proguanil hydrochloride.
Jamaludin A; Mohamad M; Navaratnam V; Yeoh PY; Wernsdorfer WH
Trop Med Parasitol; 1990 Sep; 41(3):268-72. PubMed ID: 2255843
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic oxidative metabolism of proguanil in a Nigerian population.
Bolaji OO; Sadare IO; Babalola CP; Ogunbona FA
Eur J Clin Pharmacol; 2002 Nov; 58(8):543-5. PubMed ID: 12451432
[TBL] [Abstract][Full Text] [Related]
15. Single dose pharmacokinetics of proguanil and its metabolites in pregnancy.
Wangboonskul J; White NJ; Nosten F; ter Kuile F; Moody RR; Taylor RB
Eur J Clin Pharmacol; 1993; 44(3):247-51. PubMed ID: 8491239
[TBL] [Abstract][Full Text] [Related]
16. A statistical analysis of the antimalarial activity of proguanil and cycloguanil in human volunteers.
Yeo AE; Edstein MD; Shanks GD; Rieckmann KH
Ann Trop Med Parasitol; 1994 Dec; 88(6):587-94. PubMed ID: 7893172
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil.
McGready R; Stepniewska K; Seaton E; Cho T; Cho D; Ginsberg A; Edstein MD; Ashley E; Looareesuwan S; White NJ; Nosten F
Eur J Clin Pharmacol; 2003 Oct; 59(7):553-7. PubMed ID: 12955370
[TBL] [Abstract][Full Text] [Related]
18. A preliminary pharmacokinetic study of the antimalarial drugs, proguanil and chlorproguanil.
Watkins WM; Chulay JD; Sixsmith DG; Spencer HC; Howells RE
J Pharm Pharmacol; 1987 Apr; 39(4):261-5. PubMed ID: 2884288
[TBL] [Abstract][Full Text] [Related]
19. Effect of proguanil and cycloguanil on human lymphocytes in vitro.
Bygbjerg IC
Eur J Clin Pharmacol; 1985; 28(3):287-90. PubMed ID: 3874067
[TBL] [Abstract][Full Text] [Related]
20. Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects.
Wattanagoon Y; Taylor RB; Moody RR; Ochekpe NA; Looareesuwan S; White NJ
Br J Clin Pharmacol; 1987 Dec; 24(6):775-80. PubMed ID: 3440097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]